login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Industry-sponsored Drug Trials Portray a Tendency to Publish Favourable Results
When published results are systematically tracked for drug trials registered with ClinicalTrials.gov, those from industry-funded trials are the likeliest to be favourable to the drug in question, according to researchers at Children's Hospital Boston.
The researchers said there should be more public disclosure about clinical drug trials at their outset to reduce the possibility of bias in the findings.
The research team, led by Florence Bourgeois, of Children's Division of Emergency Medicine, and Kenneth Mandl, Laboratory Director in the Children's Hospital Informatics Program, reviewed 546 drug trials conducted between 2000 and 2006 and listed with ClinicalTrials.gov, a comprehensive, web-based federal registry of clinical trials.
The analysis focused on five classes of drugs: cholesterol-lowering drugs, antidepressants, antipsychotics, proton-pump inhibitors and vasodilators. The researchers scanned the medical literature for publications associated with each trial, checking four separate databases and contacting trial investigators directly if necessary.
Overall, allowing for a three-year lag time from the completion of the trial, two-thirds of the trials had published results.
The industry-funded trials reported positive outcomes 85 percent of the time, as compared with 50 percent for government-funded trials and 72 percent for trials funded by nonprofits or non-federal organizations.
In addition, among the nonprofit/nonfederal trials, those that had industry contributions (nearly half) were more likely than those without to report positive outcomes (85 vs. 61 percent).
|
|
|
More News on: Drug Toxicity, Clinical Trials, Clinical Trials - The Past and The Future , Clinical Trials - Different Phases of the trial , Signature Drug Toxicity, Amyotrophic Lateral Sclerosis (ALS)
 Comment & Contribute
|
- Health News Index
- News Quick Links
| News Categories: |
| » | Cardio-Pulmonary Function can be a Strong Indicator for Survival Chances of Breast Cancer Patients |
| » | Post Surgery Will the Tumour Return? New Breast Cancer Test to Predict Exactly |
| » | Scientists Develop Compound That Triggers Cancer Cell Death |
| » | Iraqi National Hopes to Find Affordable Treatment for His Cancer in India |
| » | New Technique can Help Doctors Detect Pancreatic Cancer |
| More Cancer News | |
|
